FrancophonIA/ELRC3.0 huggingface dataset:
English: Drug reaction with eosinophilia and systemic symptoms (DRESS).
Croatian: Reakcija na lijek s eozinofilijom i sistemskim simptomima (DRESS), preosjetljivost (uključujući angioedem i anafilaksiju)
English: Rare (may affect up to 1 in 1,000 people)
Croatian: Rijetko (mogu se javiti u manje od 1 na 1000 osoba)
English: Vial of 5 ml
Croatian: Bočica od 5 ml
English: Blood methotrexate and levetiracetam levels should be carefully monitored in patients treated concomitantly with the two drugs.
Croatian: U bolesnika koji su usporedno liječeni s oba dva lijeka, koncentraciju metotreksata i levetiracetama u krvi treba pažljivo nadzirati.
English: No adverse reactions on male or female fertility or reproduction performance were observed in rats at doses up to 1,800 mg/kg/day (x 6 the MRHD on a mg/m2 or exposure basis) in parents and F1 generation.
Croatian: Kod mužjaka i ženki štakora roditeljske i F1 generacije nisu primijećeni štetni učinci na plodnost ili na reprodukciju u dozama do 1800 mg/kg/dan (6-erostruka vrijednost najveće preporučene doze za čovjeka izražena u mg/m2 ili na osnovnu izloženost).
English: A 750 mg loading dose is recommended on the first day of treatment with levetiracetam.
Croatian: Prvog dana liječenja levetiracetamom preporučuje se udarna doza od 750 mg.
English: Levetiracetam Hospira is used: on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy, to treat a certain form of epilepsy.
Croatian: • samostalno u odraslih i adolescenata od 16. godine života s novodijagnosticiranom epilepsijom, u liječenju određenog oblika epilepsije.
English: Ca currents and by reducing the release of Ca from intraneuronal stores.
Croatian: N tip protoka Ca i smanjuje otpuštanje Ca iz skladišta u neuronima.
English: Choreoathetosis, dyskinesia, hyperkinesia, gait disturbance, encephalopathy
Croatian: Koreoatetoza, diskinezija, hiperkinezija, poremećaji hodanja, encefalopatija
English: Maximum dose: 30 mg/kg twice daily
Croatian: Najveća doza: 30 mg/kg dva puta na dan
English: A peri- and post-natal development study was performed in rats with levetiracetam doses of 70, 350 and 1,800 mg/kg/day.
Croatian: Studija peri- i postnatalnog razvoja provedena je u štakora dozama levetiracetama od 70, 350 i
English: Levetiracetam Hospira concentrate for solution for infusion is an alternative for patients when administration of the antiepileptic levetiracetammedicine by mouth is temporarily not feasible.
Croatian: Levetiracetam Hospira koncentrat za otopinu za infuziju se koristi kao alternativnilijek kod bolesnika kod kojih privremenonije moguće primijenitiantiepileptik levetiracetamkroz usta.
English: Infusion Time Frequency of administration
Croatian: Vrijeme infuzije
English: Levetiracetam Hospira contains sodium
Croatian: Levetiracetam Hospira sadrži natrij
English: Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.
Croatian: Monoterapija u liječenju parcijalnih napadaja sa sekundarnom generalizacijom ili bez nje u bolesnika od navršene 16. godine života s novodijagnosticiranom epilepsijom.
English: The administration of levetiracetam to patients with renal impairment may require dose adjustment.
Croatian: U bolesnika s oštećenjem bubrega može biti potrebno prilagođavanje doze levetiracetama.
English: Adjunctive therapy in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
Croatian: Dodatna terapija primarno generaliziranih toničko-kloničkih napadaja u odraslih i adolescenata od 12 godina života s idiopatskom generaliziranom epilepsijom.
English: Creatinine clearance (ml/min/1.73 m
Croatian: Klirens kreatinina (ml/min/1,73 m
English: Creatinine clearance (ml/min/1.73m
Croatian: Klirens kreatinina (ml/min/1,73m
English: 1,500 mg 15 ml (three 5 ml vials)
Croatian: 1500 mg 15 ml (tri bočice od 5 ml)
English: See the package leaflet for further information.
Croatian: Za dodatne informacije pogledati uputu o lijeku.
English: 500 mg 5 ml (one 5 ml vial)
Croatian: 500 mg 5 ml (jedna bočica od 5 ml)
English: In the elderly, the half-life is increased by about 40% (10 to 11 hours).
Croatian: U starijih osoba poluvijek u plazmi povećan je za oko 40% (10 do 11 sati), što je u svezi sa smanjenjem bubrežne funkcije unutar te populacije (vidjeti dio 4.2).
English: • in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
Croatian: • u liječenju miokloničkih napadaja u odraslih i adolescenata od 12. godine života s juvenilnom miokloničkom epilepsijom.
English: Levetiracetam Hospira is for intravenous use.
Croatian: Levetiracetam Hospira je namijenjen za primjenu u venu.
English: Linear and dose proportional increases were observed for peak plasma concentrations and area under the curve.
Croatian: Za vršne koncentracije u plazmi i površinu ispod krivulje primijećena su linearna povećanja i povećanja proporcionalna s dozom.
English: Preparation and administration of Levetiracetam Hospira concentrate for solution for infusion Dose
Croatian: Priprema i primjena Levetiracetam Hospira koncentrata za otopinu za infuziju Doza Volumen koji se izvlači iz bočice
English: In this study, levetiracetam, dose was 3,000 mg/day given in 2 divided doses.
Croatian: Primijenjena doza kod studije bila je 3000 mg/dan podjeljeno na dvije doze.
English: lethargy (lack of energy and enthusiasm), tremor (involuntary trembling);
Croatian: • konvulzije, poremećaj ravnoteže, omaglica (osjećaj nestabilnosti), letargija (nedostatak energije i entuzijazma), tremor (nevoljno drhtanje);
English: Adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
Croatian: Dodatna terapija miokloničkih napadaja u odraslih i adolescenata od 12 godina života s juvenilnom miokloničkom epilepsijom.
English: The NOAEL (No Observed Adverse Effect Level) was 3600 mg/kg/day for pregnant female rats (x 12 the MRHD on a mg/m2 basis) and
Croatian: NOAEL (No Observed Adverse Effect Level, razina pri kojoj se ne uočava štetni učinak) za gravidne štakorice iznosila je 3600 mg/kg/dan, a za fetuse 1200 mg/kg/dan (12-erostruka vrijednost najveće preporučene doze za čovjeka izražena u mg/m
English: 250 mg 2.5 ml (half 5 ml vial) 100 ml
Croatian: 250 mg 2,5 ml (pola bočice od 5 ml)
English: Abdominal pain, diarrhoea, dyspepsia, vomiting, nausea
Croatian: Bol u trbuhu, dijareja, dispepsija, povraćanje, mučnina
English: Levetiracetam Hospira 100 mg/ml concentrate for solution for infusion levetiracetam
Croatian: Levetiracetam Hospira 100 mg/ml koncentrat za otopinu za infuziju levetiracetam
English: • amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia
Croatian: • amnezija (gubitak pamćenja), smetnje pamćenja (zaboravljivost), poremećaj koordinacije/ataksija (poremećaj koordinacije pokreta), parestezija (trnci), smetnje u koncentraciji (gubitak koncentracije);
English: 500 to 1,000 mg once daily
Croatian: 500 do 1000 mg jedanput na dan
English: Add-on therapy for adults (≥18 years) and adolescents (12 to 17 years) weighing 50 kg or more The initial therapeutic dose is 500 mg twice daily.
Croatian: Dodatna terapija za odrasle (≥18 godina) i adolescente (12 do 17 godina) teške 50 kg ili više
English: End-stage renal disease patients undergoing dialysis
Croatian: Bolesnici u krajnjoj fazi bubrežne bolesti koji su na dijalizi
English: Pancytopenia, neutropenia agranulocytosis
Croatian: Pancitopenija, neutropenija, agranulocitoza
English: The intravenous formulation is an alternative to your oral administration.
Croatian: Intravenski oblik predstavlja drugu mogućnost primjeni lijeka kroz usta.
English: Clear, colourless solution
Croatian: Bistra, bezbojna otopina.
English: Preparation and administration of Levetiracetam Hospira concentrate Dose
Croatian: Priprema i primjena Levetiracetam Hospira koncentrata Doza Volumen koji se izvlači iz bočice
English: Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalization in adults, adolescents and children from 4 years of age with epilepsy.
Croatian: Dodatna terapija parcijalnih napadaja sa sekundarnom generalizacijom ili bez nje u odraslih, adolescenata i djece od 4.godine života nadalje koji pate od epilepsije.
English: 1,000 mg 10 ml (two 5 ml vials) 100 ml
Croatian: 1000 mg 10 ml (dvije bočice od 5 ml)
English: • abdominal pain, diarrhoea, dyspepsia (indigestion), vomiting, nausea;
Croatian: • bol u trbuhu, proljev, dispepsija (probavne tegobe), povraćanje, mučnina;
English: Add-on therapy for children aged 4 to 11 years and adolescents (12 to 17 years) weighing less than 50 kg The initial therapeutic dose is 10 mg/kg twice daily.
Croatian: Dodatna terapija za djecu u dobi od 4 do 11 godina i adolescente (12 do 17 godina) s manje od 50 kg tjelesne težine
English: Each 5 ml vial contains 500 mg of levetiracetam.
Croatian: Jedna bočica s 5 ml sadrži 500 mg levetiracetama.
English: Methotrexate
Croatian: Nuspojave
English: One vial contains 500 mg/5 ml levetiracetam.
Croatian: Jedna bočica sadrži 500 mg/5 ml levetiracetama.
English: From 50 kg
Croatian: Iznad 50 kg
English: 150 mg twice daily
Croatian: 150 mg dva puta na dan
English: Excretion via faeces accounted for only 0.3% of the dose.
Croatian: Samo 0,3% doze izlučuje se fecesom.
English: 600 mg twice daily
Croatian: 600 mg dva puta na dan
English: 200 mg twice daily
Croatian: 200 mg dva puta na dan
English: To be taken into consideration by patients on a controlled sodium diet.
Croatian: Treba uzeti u obzir kod bolesnika koji moraju ograničiti unos natrija.
English: 450 mg twice daily
Croatian: 450 mg dva puta na dan
English: Levetiracetam Hospira 100 mg/ml concentrate for solution for infusion
Croatian: Levetiracetam Hospira 100 mg/ml koncentrat za otopinu za infuziju
English: Dose in adults and adolescents (12 to 17 years) weighing 50 kg or more: General dose: between 1,000 mg and 3,000 mg each day.
Croatian: Doza u odraslih i adolescenata (12 do 17 godina) koji imaju 50 kg ili više:
English: Uncommon (may affect up to 1 in 100 people)
Croatian: Manje često (mogu se javiti u manje od 1 na 100 osoba)
English: 10 to 20 mg/kg (0.10 to 0.20 ml/kg) once daily A 15 mg/kg (0.15 ml/kg) loading dose is recommended on the first day of treatment with levetiracetam.
Croatian: Prvog dana liječenja levetiracetamom preporučuje se udarna doza od 15 mg/kg (0,15 ml/kg).
English: How Levetiracetam Hospira is given
Croatian: Kako primjenjivati Levetiracetam Hospira
English: Dose in children (4 to 11 years) and adolescents (12 to 17 years) weighing less than 50 kg: General dose: between 20 mg per kg bodyweight and 60 mg per kg bodyweight each day.
Croatian: Doza u djece (4 do 11 godina) i adolescenata (12 do 17 godina) koji imaju manje od 50 kg:
English: Twice daily 1,000 mg/day
Croatian: 1000 mg/dan
English: If you get any side effects talk to your doctor or pharmacist.
Croatian: - Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika ili ljekarnika.
English: Discontinuation
Croatian: Predoziranje
English: Serum Creatinine (mg/dl)
Croatian: CLcr (ml/min/1,73 m kreatinin u serumu (mg/dl)
English: Twice daily 3,000 mg/day
Croatian: 3000 mg/dan
English: Asthenia/fatigue
Croatian: Astenija/umor
English: (See sections 4.5 and 5.2.)
Croatian: (Vidjeti dijelove 4.5 i 5.2.)
English: See section 4.
Croatian: Pogledajte dio 4
English: Put the tablet in your mouth.
Croatian: Stavite tabletu u usta.
English: If you are pregnant or breast-feeding, think you might may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Croatian: Ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete, obratite se svom liječniku za savjet prije nego uzmete ovaj lijek.
English: However, the marketing authorisation holder shall submit periodic safety update reports for this medicinal product if the product is included in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal.
Croatian: Međutim, nositelj odobrenja podnosi periodična izvješća za sigurnost ovog lijeka update, ako je proizvod uključen u popis unije referentnih datuma (EURD list) predviđen člankom 107c (7) Direktive 2001/83/EZ i objaviti naEuropska medicinska web-portal.
English: - If you have been previously diagnosed with eye problems such as certain kinds of glaucoma (increased pressure in the eye).
Croatian: • Ako od ranije imate dijagnosticirane tegobe s očima kao što su određene vrste glaukoma (povišeni očni tlak).
English: It will dissolve directly in your mouth, so it can be easily swallowed.
Croatian: Rastopit će se izravno u ustima te se može lako progutati.
English: Date of first authorisation: 10.12.2009 Date of renewal of authorisation: 06.08.2014
Croatian: Datum posljednje obnove: 06.08.2014.
English: At the time of granting the marketing authorisation, the submission of periodic safety update reports is not required for this medicinal product.
Croatian: U vrijeme davanju odobrenja, podnošenje redovitih izvješća sigurnosnih nadogradnji nije potrebna za ovog lijeka.
English: Talk to your doctor or pharmacist before you take Olazax Disperzi.
Croatian: Obratite se svom liječniku ili ljekarniku prije nego uzmete Olazax Disperzi.
English: • unusual movement (a common side effect that may affect up to 1 in 10 people) mainly of the face or tongue;
Croatian: • neuobičajene pokrete (česta nuspojava koja se može pojaviti u najviše 1 na 10 osoba) uglavnom na licu ili jeziku;
English: Do not use epinephrine, dopamine, or other sympathomimetic agents with betaagonist activity since beta stimulation may worsen hypotension.
Croatian: Ne koristite epinefrin, dopamin ili druge simpatomimetike s beta-agonističkim djelovanjem jer beta stimulacija može pogoršati hipotenziju.
English: Detailed information on this medicine is available on the European Medicines Agency (EMA) website: http://www.ema.europa.eu
Croatian: Detaljnije informacije o ovom lijeku dostupne su na web stranici Europske agencije za lijekove: http://www.ema.europa.eu
English: Store below 30 C.
Croatian: Čuvati na temperaturi ispod 30ºC.
English: The frequency terms listed are defined as follows: Very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 10,000), not known (cannot be estimated from the data available).
Croatian: Učestalost je definirana kako slijedi: vrlo često (≥ 1/10), često (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (< 1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
English: Olazax Disperzi with alcohol
Croatian: Olazax Disperzi s alkoholom
English: Olanzapine is bound predominantly to albumin and 1-acid-glycoprotein.
Croatian: Olanzapin se prvenstveno veže za albumin i α1-kiseli-glikoprotein.
English: • carbamazepine (an anti-epileptic and mood stabiliser), fluvoxamine (an antidepressant) or ciprofloxacin (an antibiotic) - it may be necessary to change your Olazax Disperzi dose.
Croatian: • karbamazepin (antiepileptik i stabilizator raspoloženja), fluvoksamin (antidepresiv) ili ciprofloksacin (antibiotik) - možda će biti potrebno promijeniti dozu lijeka Olazax Disperzi.
English: You should not be given this medicine when breast-feeding, as small amounts of Olazax Disperzi can pass into breast milk.
Croatian: Ne biste smjeli uzimati ovaj lijek dok dojite, jer se male količine lijeka Olazax Disperzi mogu izlučiti u majčino mlijeko.
English: Children and adolescents Olazax Disperzi is not for patients who are under 18 years.
Croatian: Djeca i adolescenti Olazax Disperzi nije za primjenu u bolesnika mlađih od 18 godina.
English: Other medicines and Olazax Disperzi
Croatian: Drugi lijekovi i Olazax Disperzi
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ALUMINIUM BLISTERS
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP ALUMINIJSKI BLISTERI
English: In patients with Parkinson's disease Olazax Disperzi may worsen the symptoms
Croatian: U bolesnika koji boluju od Parkinsonove bolesti, Olazax Disperzi može pogoršati simptome.
English: The magnitude of weight gain and the proportion of adolescent patients who had clinically significant weight gain were greater with longterm exposure (at least 24 weeks) than with short-term exposure.
Croatian: Povećanje tjelesne težine i udio adolescentnih bolesnika koji su imali klinički značajno povećanje tjelesne težine bili su veći tijekom dugotrajnog izlaganja (najmanje 24 tjedana) nego tijekom kratkotrajnog izlaganja lijeku.
English: Do not drink any alcohol if you have been given Olazax Disperzi as together with alcohol it may make you feel drowsy.
Croatian: Nemojte piti alkohol ako uzimate Olazax Disperzi jer u kombinaciji s alkoholom može izazvati omamljenost.
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMA) http://www.ema.europa.eu
Croatian: Detaljnije informacije o ovom lijeku dostupne su na web stranici Europske agencije za lijekove http://www.ema.europa.eu.
English: Your doctor will tell you how many Olazax Disperzi tablets to take and how long you should continue to take them.
Croatian: Liječnik će Vam reći koliko Olanzapin Glenmark Europe raspadljivih tableta za usta trebate uzeti i koliko ćete ih dugo uzimati.
English: However the risk of tardive dyskinesia increases with long term exposure, and therefore if signs or symptoms of tardive dyskinesia appear in a patient on olanzapine, a dose reduction or discontinuation should be considered.
Croatian: Međutim, rizik od tardivne diskinezije povećava se s dugotrajnom izloženošću te u slučaju pojave znakova ili simptoma tardivne diskinezije u bolesnika na olanzapinu treba razmotriti snižavanje doze ili prekid liječenja.
English: LIST OF EXCIPIENTS Contains aspartame.
Croatian: POPIS POMOĆNIH TVARI Sadrži aspartam.
English: Pancreatitis11
Croatian: pankreatitis11
English: Schizophrenia: The recommended starting dose for olanzapine is 10 mg/day.
Croatian: Shizofrenija: preporučena početna doza olanzapina je 10 mg/dan.
English: If this happens after you have been given Olazax Disperzi tell your doctor.
Croatian: Ako Vam se ovo pojavi nakon uzimanja lijeka Olazax Disperzi, obratite se svom liječniku.
English: Olazax Disperzi orodispersible tablets should be placed in the mouth, where it will rapidly disperse in saliva, so it can be easily swallowed.
Croatian: Olazax Disperzi raspadljivu tabletu za usta treba staviti u usta, gdje se brzo rastapa u slini te se može lako progutati.
English: During treatment for schizophrenia, manic episode and recurrence prevention in bipolar disorder, daily dosage may subsequently be adjusted on the basis of individual clinical status within the range 5-20 mg/day.
Croatian: Tijekom liječenja shizofrenije, epizode manije te prevencije relapsa bipolarnog poremećaja, dnevna doza se može naknadno podesiti na temelju kliničke slike pojedinog bolesnika u rasponu od 5 do 20 mg/dan.
English: 6.5 Nature and contents of container Aluminium/aluminium blisters in cartons of 28, 56 tablets per carton.
Croatian: 6.5 Vrsta i sadržaj spremnika Aluminij/aluminij blisteri u kutijama s 28 & 56 tableta.
English: • Weight gain has been seen in patients taking Olazax Disperzi.
Croatian: • Zapaženo je povećanje tjelesne težine u bolesnika koji uzimaju Olazax Disperzi.
English: PHARMACEUTICAL FORM AND CONTENTS Orodispersible Tablet 28 orodispersible tablets 56 orodispersible tablets METHOD AND ROUTE(S) OF ADMINISTRATION The tablet should be dissolved in the mouth or in a drink.
Croatian: OBLIK I SADRŽAJ Raspadljiva tableta za usta 28 raspadljivih tableta za usta 56 raspadljivih tableta za usta NAČIN I PUT(EVI) PRIMJENE LIJEKA Tabletu treba otopiti u ustima ili nekom napitku.
English: Alternatively, it may be dispersed in a full glass of water or other suitable beverage (orange juice, apple juice, milk or coffee) immediately before the administration.
Croatian: Alternativno se može rastopiti u čaši punoj vode ili nekom drugom prikladnom napitku (soku od naranče, soku od jabuke, mlijeku ili kavi) netom prije primjene.
English: What Olazax Disperzi is and what it is used for What you need to know before you take Olazax Disperzi How to take Olazax Disperzi Possible side effects
Croatian: Što je Olazax Disperzi i za što se koristi Što morate znati prije nego počnete uzimati Olazax Disperzi
English: The mean increase in olanzapine Cmax following fluvoxamine was 54 % in female nonsmokers and 77 % male smokers.
Croatian: Srednja vrijednost porasta Cmax olanzapina nakon primjene fluvoksamina iznosila je 54% u žena nepušača i 77% u muškaraca pušača.
English: Magnesium stearate
Croatian: krospovidon magnezijev stearat
English: • blood clots in the veins (an uncommon side effect that may affect up to 1 in 100 people) especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing.
Croatian: • krvne ugruške u venama (manje česta nuspojava koja se može pojaviti u najviše 1 na 100 osoba), posebno u nogama (simptomi uključuju oticanje, bol i crvenilo nogu), koji mogu putovati krvnim žilama do pluća, uzrokujući bol u prsima i otežano disanje.
English: Olanzapine should be used cautiously in patients who have a history of seizures or are subject to factors which may lower the seizure threshold.
Croatian: Olanzapin treba oprezno primjenjivati u bolesnika imaju napadaje u anamnezi ili su izloženi čimbenicima koji mogu sniziti prag za napadaje.
English: 6.4 Special precautions for storage Store below 30 C.
Croatian: 6.4 Posebne mjere pri čuvanju lijeka Čuvati na temperaturi ispod 30ºC.
English: What you need to know before you take Olazax Disperzi
Croatian: Što morate znati prije nego počnete uzimati Olazax Disperzi
English: In these trials, patients were initially required to be stable on the lowest effective dose of anti-Parkinsonian medicinal products (dopamine agonist) and to remain on the same anti-Parkinsonian medicinal products and dosages throughout the study.
Croatian: Na početku ovih ispitivanja bolesnici su morali biti stabilni na najnižoj učinkovitoj dozi antiparkinsonika (agonisti dopamina) te su na istom antiparkinsoniku i pri istoj dozi morali ostati tijekom cijelog ispitivanja.
English: • The use of Olazax Disperzi in elderly patients with dementia is not recommended as it may have serious side effects.
Croatian: • Primjena lijeka Olazax Disperzi u starijih bolesnika s demencijom (zaboravljivošću) se ne preporučuje jer mogu nastati teške nuspojave.
English: In a multinational, double-blind, comparative study of schizophrenia, schizoaffective, and related disorders which included 1,481 patients with varying degrees of associated depressive symptoms (baseline mean of 16.6 on the Montgomery-Asberg Depression Rating Scale), a prospective secondary analysis of baseline to endpoint mood score change demonstrated a statistically significant improvement (p= 0.001) favouring olanzapine (- 6.0) versus haloperidol (- 3.1).
Croatian: U multinacionalnom, dvostruko slijepom, komparativnom ispitivanju shizofrenije, shizoafektivnih i povezanih poremećaja, koje je obuhvaćalo 1481 bolesnika s različitim stupnjevima pridruženih simptoma depresije (srednja početna vrijednost 16,6 po Montgomery-Asberg ljestvici depresije), prospektivna sekundarna analiza vrijednosti promjene raspoloženja od početnog do krajnjeg pokazala je statistički značajno poboljšanje (p=0,001) u korist olanzapina (-6,0) u odnosu na haloperidol (-3,1).
English: - The other ingredients are mannitol (E 421), microcrystalline cellulose, aspartame (E 951), crospovidone, magnesium stearate
Croatian: Drugi sastojci su manitol (E 421), mikrokristalična celuloza, aspartam (E 951), krospovidon, magnezijev stearat
English: What Olazax Disperzi looks like and contents of the pack
Croatian: Kako Olazax Disperzi izgleda i sadržaj pakiranja